Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when EHTH files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertseHealth reports Q1 revenue down 22% to $88M, posts $4.7M loss on $6.4M restructuring charges
Filed May 6, 2026 · Period ending May 3, 2026 · ~1 min read
Key Changes
-
high
Q1 2026 revenue fell 22% YoY to $88.0M as eHealth deliberately reduced Medicare enrollment volumes to focus on profitable marketing channels; GAAP net loss of $4.7M vs. $2.0M profit in Q1 2025, driven by $6.4M in workforce reduction charges.
Item 2.02 — Results of Operations and Financial Condition verify on EDGAR → -
high
Medicare unit economics improved with LTV-to-CAC ratio rising to 1.4x from 1.2x as acquisition costs fell 10% and lifetime value increased 3%, despite 45% reduction in variable marketing spend.
Item 2.02 — Results of Operations and Financial Condition verify on EDGAR → -
high
Company reaffirmed FY 2026 guidance of $405-445M revenue and $8-25M GAAP net income; updated positive net adjustment revenue expectation to $8-20M from prior $0-20M range based on Q1 results.
Item 2.02 — Results of Operations and Financial Condition verify on EDGAR → -
medium
Director Cesar Soriano will resign effective June 18, 2026 to focus on his CEO role at Confie Corporation; board size will reduce from ten to eight members following his departure and Andrea Brimmer's previously disclosed term expiration.
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR → -
medium
eHealth launched lifetime advisory model and final expense insurance product in April 2026, diversifying beyond traditional Medicare and individual health insurance offerings.
Item 2.02 — Results of Operations and Financial Condition verify on EDGAR →
Summary
eHealth reported first quarter 2026 results that reflect a deliberate strategic pivot toward profitability over growth. Revenue declined 22% to $88.0 million as the company reduced Medicare enrollment volumes and cut variable marketing spend by 45%, focusing resources on higher-return channels.
The quarter's $4.7 million GAAP net loss was driven entirely by $6.4 million in restructuring charges from workforce reductions; excluding these one-time costs, the company would have been profitable with $9.0 million in adjusted EBITDA. The strategy is showing early traction in unit economics.
Medicare's lifetime-value-to-customer-acquisition-cost ratio improved from 1.2x to 1.4x as the company spent less to acquire each customer while extracting more lifetime value. Management reaffirmed full-year guidance projecting a return to profitability with $8-25 million in GAAP net income and outlined a multi-year roadmap targeting mid-teens revenue growth and 20% adjusted EBITDA margins by 2028. The board will shrink from ten to eight members at the June annual meeting following Cesar Soriano's resignation to focus on his Confie CEO role and Andrea Brimmer's previously announced departure. For investors, the quarter validates management's thesis that sacrificing near-term revenue to improve customer economics can restore sustainable profitability, though execution risk remains as the company navigates this transition year.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
eHealth disclosed Q1 2026 financial results via press release and supplemental investor materials posted to its investor relations website.
Added in current filing · verify on EDGAR →
On May 6, 2026, eHealth, Inc. (the “Company”) issued a press release announcing its financial results for the three months ended March 31, 2026 and its financial condition as of March 31, 2026.
The company announced its first quarter 2026 financial results through a press release. The 8-K itself does not contain the actual financial figures — those are in the attached press release exhibit. This is a standard quarterly earnings disclosure mechanism.
Added in current filing · verify on EDGAR →
On May 6, 2026, the Company posted supplemental investor material on its investor relations webpage at https://ir.ehealthinsurance.com. The Company intends to use its investor relations webpage as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.
eHealth posted additional investor materials to its website alongside the earnings release. The company explicitly states it will use this webpage to disclose material non-public information and comply with Regulation FD fair disclosure requirements, signaling this as an official channel for material updates.
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On May 3, 2026, Cesar Soriano notified the board of directors of eHealth, Inc. (the “Board”) of his decision to resign from the Board, including all committees thereof, effective immediately prior to the commencement of the Company’s 2026 Annual Meeting of Stockholders currently scheduled for June 18, 2026, at 9:00 a.m. Eastern Time.
Director Cesar Soriano will resign from the board and all committees effective immediately before the June 18, 2026 annual meeting. The resignation is voluntary and not due to any disagreement with the company.
Added in current filing · verify on EDGAR →
In connection with Mr. Soriano’s resignation and with the expiration of Andrea Brimmer’s term as a member of the Board at the 2026 Annual Meeting of Stockholders, as previously disclosed on March 31, 2026, the Board intends to reduce the size of the Board from ten to eight members, effective as of the date of the 2026 Annual Meeting of Stockholders.
The board will shrink from ten to eight members at the annual meeting, reflecting both Soriano's resignation and Andrea Brimmer's previously disclosed term expiration. This represents a 20% reduction in board size.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
Mr. Soriano’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices. The decision reflects his desire to focus on the increasing demands of his role as Chief Executive Officer of Confie Corporation.
Soriano is leaving to focus on his CEO responsibilities at Confie Corporation, not due to any issues with eHealth. This is a routine departure driven by competing time commitments.
Event · Exhibit 99.1
Added in current filing · view on EDGAR →
Q1 2026 total revenue of $88.0 million decreased 22% compared to Q1 2025 total revenue of $113.1 million, reflecting lower Medicare approved members, consistent with our strategy to reduce variable and fixed expenses in fiscal 2026 and focus demand generation on our more profitable marketing channels.
Total revenue fell 22% year-over-year to $88.0 million, driven by lower Medicare enrollment volumes as the company deliberately reduced marketing spend to focus on more profitable channels. Despite lower revenue, the company improved Medicare segment gross margin to 41% from 34% and reduced total operating costs by 16%.
Added in current filing · view on EDGAR →
Q1 2026 GAAP net loss of $4.7 million compared to Q1 2025 GAAP net income of $2.0 million primarily due to Q1 2026 restructuring charges of $6.4 million.
The company recorded $6.4 million in restructuring charges during Q1 2026, which drove the swing from a $2.0 million profit in Q1 2025 to a $4.7 million loss this quarter. These charges are part of the company's plan to reduce total FY 2026 operating costs by approximately $90 million.
Event · Exhibit 99.2
Added in current filing · view on EDGAR →
Q1 2026 total revenue of $88.0 million decreased 22% YoY reflecting lower Medicare Advantage (“MA”) approved members consistent with our strategy to reduce variable and fixed expenses in ‘26 and focus demand generation on most profitable marketing channels.
eHealth reported Q1 2026 revenue of $88.0 million, down 22% year-over-year from $113.1 million in Q1 2025. The decline was driven by lower Medicare Advantage enrollment volumes as the company strategically reduced marketing spend to focus on high-ROI channels. This was an intentional shift to improve profitability and unit economics rather than maximize enrollment volume.
Added in current filing · view on EDGAR →
Q1 2026 GAAP net loss of $4.7 million compared to GAAP net income of $2.0 million a year ago. Q1 2026 GAAP net loss margin of 5% compared to Q1 2025 GAAP net income margin of 2%. ... Q1 2026 GAAP net loss YoY change was primarily due to restructuring charges of $6.4M booked in connection with our workforce reduction.
The company reported a GAAP net loss of $4.7 million in Q1 2026 versus net income of $2.0 million in Q1 2025. The swing to loss was primarily driven by $6.4 million in restructuring charges related to a workforce reduction. Excluding these one-time charges, underlying profitability would have been positive, with adjusted EBITDA of $9.0 million.
Added in current filing · view on EDGAR → · paraphrased
Q1 2026 Medicare unit economics improved YoY driven by a 3% increase in MA LTV and a 10% decrease in total acquisition cost per MA-equivalent approved member(1). Q1 2026 Medicare LTV-to-CAC ratio(1) was 1.4x, an improvement from 1.2x in Q1 2025. ... Variable marketing spend within our Medicare segment declined 45% YoY.
Despite lower enrollment volumes, eHealth improved its Medicare business profitability metrics. Medicare Advantage lifetime value increased 3% to $938 while total acquisition cost per member decreased 10% to $676, driven by a 45% reduction in variable marketing spend. The LTV-to-CAC ratio improved from 1.2x to 1.4x, indicating each dollar spent on customer acquisition generates more lifetime value.
Added in current filing · view on EDGAR →
Total Revenue $405 – $445 ... GAAP Net Income $8 – $25 ... Adjusted EBITDA(1) $55 – $75 ... Operating Cash Flow ($10) – $12 ... 2026 guidance includes the expected impact of positive net adjustment revenue which has been updated to be in the range of $8 million to $20 million to reflect the Q1 2026 positive net adjustment revenue, compared to the previous range of $0 to $20 million.
eHealth provided full-year 2026 guidance with revenue of $405-$445 million, GAAP net income of $8-$25 million, adjusted EBITDA of $55-$75 million, and operating cash flow of negative $10 million to positive $12 million. The company updated its positive net adjustment revenue expectation to $8-$20 million from the prior $0-$20 million range based on Q1 results.
Added in current filing · view on EDGAR →
2027: Mid-single digit percentage growth YoY ... 2028: Mid-teens percentage growth YoY ... Adjusted EBITDA margin(1) (2) expansion in ‘27 and ‘28 ... Reaching 20% adjusted EBITDA margin(1) (2) by ‘28 ... 2027: Positive operating cash flow, breakeven free cash flow(1) (2) ... 2028: Positive operating and free cash flow(1) (2)
eHealth outlined multi-year targets positioning 2026 as a transition year with return to growth in 2027. The company expects mid-single-digit revenue growth in 2027 and mid-teens growth in 2028, with adjusted EBITDA margin reaching 20% by 2028. Cash flow is expected to turn positive in 2027 for operations and breakeven for free cash flow, with both positive in 2028.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jul 1, 2026 · How we verify